Parenteral Drugs (India) Ltd.
Snapshot View

View in App

Prices View details >>

4.34 ▼0%

27 March 2023, 04:01:00 PM

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.pdindia.com
Market Cap 12.94 Cr.
Enterprise Value(EV) 119.18 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) -25.61 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-03
Industry PE 32.17 Trailing Twelve Months Ending 2022-03
Book Value / Share -278.81 Trailing Twelve Months Ending 2022-03
Price to Book Value -0.02 Calculated using Price: 4.34
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 2.98 Cr. 29,816,300 Shares
FaceValue 10
Company Profile
Established in the year 1983, Parenteral Drugs has dedicated itself to the manufacturing of the best quality vital life saving drug at the lowest possible cost. Over the years, its path breaking innovation has led not only to lower costs but better quality as well because PDPL firmly believes that better quality dose not necessarily mean higher price, it can also be achieved by indigenous techniques and innovative technologies.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
-4.82%
1 Month
-9.39%
3 Month
-6.06%
6 Month
+19.89%
1 Year
-12.85%
2 Year
+43.71%
5 Year
-72.88%
10 Year
-95.08%

Ratios View Details >>

9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) -44.85 -23.61 -46.67 -152.43
Return on Capital Employed (%) -5.15 1.90 -2.29 -8.13 -6.91 -5.55 -35.07 -52.31
Return on Assets (%) -12.80 -5.44 -8.41 -12.60 -12.16 -13.17 -23.45 -26.72 -29.65

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 246 202 127 325 -17 -136 -447 -561 -683 -824
Non Curr. Liab. 427 456 427 440 462 370 4 -26 -59 -91
Curr. Liab. 162 166 230 300 428 593 878 1,006 1,144 1,201
Minority Int. 1 1 1 1 0 0 0 0 0 0
Equity & Liab. 835 825 785 1,066 872 827 435 419 402 286
Non Curr. Assets 629 619 549 902 750 727 368 351 334 219
Curr. Assets 192 200 235 163 122 99 67 67 68 67
Misc. Exp. not W/O 14 5 1 1
Total Assets 835 825 785 1,066 872 827 435 419 402 286

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. TTM
Net Sales 327 274 263 260 230 224 32 32 12 9
Other Income 0 61 1 2 6 2 1 0 0 0
Total Income 328 334 264 262 236 226 33 32 12 9
Total Expenditure -341 -350 -248 -296 -252 -225 -50 -47 -24 -24
PBIDT -14 -15 15 -34 -17 0 -16 -14 -12 -16
Interest -56 -60 -70 -70 -86 -98 -96 -110 -125 -106
Depreciation -23 -19 -31 -23 -25 -24 -69 -17 -17 -40
Taxation -15 1 19 10 10 10 33 28 33 33
Exceptional Items 47 0 -1 0 52
PAT -108 -45 -68 -117 -118 -112 -148 -114 -122 -76
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit -108 -45 -68 -117 -118 -112 -148 -114 -122 -76
Adjusted EPS -42 -15 -23 -39 -40 -38 -50 -38 -41 -26

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 20 -168 -60 2 58 134 167 477 112 125
Cash Fr. Inv. -147 -18 33 3 -110 -1 -1 97 0 0
Cash Fr. Finan. 133 182 25 -10 54 -134 -167 -574 -112 -125
Net Change 5 -3 -2 -5 1 0 0 0 0 0
Cash & Cash Eqvt 13 11 8 3 5 0 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%)
Promoter 73.28 73.28 73.28 73.28 73.28 73.28 73.28 73.28 73.29
Public 26.72 26.72 26.72 26.72 26.72 26.72 26.72 26.72 26.71
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 100.00 100.00 100.00 94.51 94.51 94.51 94.51 94.51 94.50

Announcements View Details >>

Sat, 11 Mar 2023
Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
This is to inform you that the Committee of Creditors of Parenteral Drugs (India) Limitedunder CIRP has been formed as on 03/03/2023 and same has been informed to Honble NCLT.
Sat, 11 Mar 2023
Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors
This is to inform you that the 1st Meeting of Committee of Creditors of Parenteral Drugs (India) Limited Under CIRP will be held on 13/03/2023 at 4:30 PM through video conference / other audio-visual method.
Sat, 11 Mar 2023
Corporate Insolvency Resolution Process (CIRP)-List of Creditors
This is to inform you that the list of Creditors of Parenteral Drugs (India) Limited Under CIRP has been prepared on 03/03/2023 and uploaded in IBBI Website on 04/03/2023 and the same has been informed to Honble NCLT

Technical Scans View Details >>

Mon, 27 Mar 2023
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
Closing Below Previous Low Closing Below Previous Low
High Decrease in 1 Month High Decrease in 1 Month
Closing Near 100 SMA Closing Near 100 SMA

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 237,702.12 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. 76,011.65 4,564.50 +0.8%
Divi's Laboratories Ltd. 74,827.63 2,818.70 +0.5%
Cipla Ltd. 71,662.87 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. 62,756.97 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. 52,113.83 1,554.65 +0.7%
Zydus Lifesciences Ltd. 49,628.37 490.30 +1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.44 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.86 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 31.22 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 27.16 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 82.20 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.32 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 24.08 490.30 +1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.30 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.45 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 6.01 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 3.16 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.19 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.25 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.88 490.30 +1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 0.04 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 490.30 +1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 490.30 +1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 490.30 +1.2%

FAQ's On Parenteral Drugs (India) Ltd.

What is Parenteral Drugs share price?
Can I buy Parenteral Drugs shares now?
What is the Market Cap of Parenteral Drugs?
What is the 52 Week High and Low of Parenteral Drugs?